Pharmafit Provence

FREESTYLE OPTIUM Electrode B/100

VIDAL information
Your professional account

PharmaFit supplies pharmacies and healthcare professionals. Access your purchasing terms and availability through your professional account.

Access is reserved for authorised professionals, following account approval.

Contact PharmaFit

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Parapharmacy
Update of 15/03/2025

FREESTYLE OPTIUM electrodes

Presentation 

Electrodes: Box of 100 (ACL 3401099724896).

Properties 

The FreeStyle Optium electrodes are designed to be used with whole capillary blood (0,6 µl) for blood glucose measurement. Result obtained in 5 seconds.

Directions for use 

Used with the FreeStyle Libre, Optium Xceed, FreeStyle Optium and FreeStyle Optium Neo readers.

ADMINISTRATIVE INFORMATION 

LPPR rate:
LPPR rate and public price: 36,02 euros including VAT (box of 100; LPPR code 1186722).
Reimbursement is provided for the following indications and conditions:
  • in type 1 diabetic patients: at least 4 SMBG/day;
  • in women with gestational diabetes: at least 4 SMBG/day;
  • in certain type 2 diabetics defined below:
    • insulin-treated patients:
      if insulin therapy includes more than one insulin injection per day: at least 4 SMBG/day,
      if insulin therapy includes a single insulin injection per day: 2 to 4 SMBG/day;
      patients in whom insulin is considered in the short or medium term and before its initiation: 2 to 4 SMBG/day;
    • patients treated with insulin secretagogues (sulfonylureas or glinides, alone or in combination with other antidiabetic treatments) in order to detect or confirm hypoglycemia and if necessary adjust the dosage of these drugs: 2 SMBG/week to 2 SMBG/day. However, reimbursement is limited to 200 electrodes per year for these patients;
    • patients in whom an improvement in glycemic control is sought when the target is not achieved, as an education tool to assess the effect of physical activity, diet and treatment: 2 SMBG/week to 2 SMBG/day. However, reimbursement is limited to 200 electrodes per year for non-insulin-requiring patients.
    Reimbursement of SMBG in type 2 diabetics must therefore not be systematic. It must be part of a well-structured approach in which patient education is important. When prescribing, it is essential to explain to the patient and organize with him or her this self-monitoring with the determination of times, frequency, targets and decisions to be taken based on the results.


ABBOTT Diabetes Care
40-48, rue d'Arcueil. CP 10457. 94593 Rungis cdx

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.